Sugi Predict

Sugi Predict / Compounds / SCHEMBL6667161

SCHEMBL6667161

SCHEMBL6667161

CCOC(=O)c1ccc(CNC(=O)c2cc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 7/20 0.60
▸ EPHX2 P34913 4/20 0.56
▸ PPARA Q07869 4/20 0.56
▸ PPARG P37231 2/20 0.56
▸ NR1H4 Q96RI1 1/20 0.52
▸ MAPK1 P28482 1/20 0.51
▸ MMP13 P45452 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.47
▸ HPGD P15428 3/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ ROCK2 O75116 1/20 0.46
▸ ROCK1 Q13464 1/20 0.46
▸ HTR2C P28335 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ PPARD Q03181 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6881395 0.90 MMP12 (0.58) MMP12EPHX2PPARAPPARGNR1H4
SCHEMBL6881932 0.89 MMP12 (0.59) MMP12EPHX2PPARAPPARGNR1H4
SCHEMBL6875177 0.89 KMT2A (0.57) MMP12EPHX2PPARGNR1H4MAPK1
SCHEMBL6663858 0.88 MMP12 (0.59) MMP12EPHX2PPARAPPARGNR1H4
SCHEMBL6875530 0.88 MMP12 (0.58) MMP12EPHX2PPARAPPARGNR1H4
SCHEMBL6881245 0.87 MMP12 (0.57) MMP12EPHX2PPARAPPARGNR1H4
SCHEMBL6875334 0.86 EPHX2 (0.52) MMP12EPHX2NR1H4CYP1A2CYP2C19
SCHEMBL6462719 0.84 MMP12 (0.64) MMP12EPHX2PPARAPPARGNR1H4
SCHEMBL6882443 0.84 MMP12 (0.52) MMP12EPHX2NR1H4MMP13ALDH1A1
SCHEMBL6456507 0.84 MMP12 (0.72) MMP12EPHX2PPARAPPARGNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them WARNER-LAMBERT COMPANY LLC 2004-04-15 — — US claimed
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them WARNER-LAMBERT COMPANY LLC 2004-04-15 — — US disclosed
WO-2004014381-A2 MATRIX METALLOPROTEINASE INHIBITORS AND METHODS FOR IDENTIFICATION OF LEAD COMPOUNDS WARNER-LAMBERT COMPANY LLC. (US) 2004-02-19 — — WO disclosed
WO-2004014867-A2 MATRIX METALLOPROTEINASE INHIBITORS AND METHODS FOR IDENTIFICATION OF LEAD COMPOUNDS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them MMP11, MMP13, CBR1 MMP12 7/4885EPHX2 1035/4885PPARA 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.